Plasma Amyloid-β Levels in Drug-Resistant Bipolar Depressed Patients Receiving Electroconvulsive Therapy

Publisher： Karger

E-ISSN： 1423-0224|67|4|185-191

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.67, Iss.4, 2013-04, pp. : 185-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Electroconvulsive Therapy Improves Clinical Manifestation with Plasma BDNF Levels Unchanged in Treatment-Resistant Depression Patients

By  

Neuropsychobiology, Vol. 68, Iss. 2, 2013-07 ,pp. : 110-115

Karger

Access to resources Recommend Favorite

Augmentation of Antipsychotics with Electroconvulsive Therapy in Treatment-Resistant Schizophrenia Patients with Dominant Negative Symptoms: A Pilot Study of Effectiveness

By  

Neuropsychobiology, Vol. 70, Iss. 3, 2014-10 ,pp. : 158-164

Karger

Access to resources Recommend Favorite

Plasma Omentin Levels in Drug-Free Patients with Schizophrenia

By  

Neuropsychobiology, Vol. 69, Iss. 3, 2014-05 ,pp. : 159-164

Karger

Access to resources Recommend Favorite

Neuropsychological Performance in Depressed and Euthymic Bipolar Patients

By  

Neuropsychobiology, Vol. 46, Iss. 1, 2003-02 ,pp. : 16-21

Karger

Access to resources Recommend Favorite

Associations between Brain-Derived Neurotrophic Factor Plasma Levels and Severity of the Illness, Recurrence and Symptoms in Depressed Patients

By  

Neuropsychobiology, Vol. 62, Iss. 4, 2010-08 ,pp. : 207-212

Karger

Access to resources Recommend Favorite